Pursuit of Profit Poisons Collaboration

Nature, vol. 532, pp. 172-173

NYLS Legal Studies Research Paper No. 2789283

2 Pages Posted: 5 Jun 2016 Last revised: 13 Feb 2017

See all articles by Jacob S. Sherkow

Jacob S. Sherkow

New York Law School; Columbia University - Department of Health Policy and Management; Center for Advanced Studies in Biomedical Innovation Law

Date Written: April 7, 2016

Abstract

The CRISPR–Cas9 patent battle demonstrates how overzealous efforts to commercialize technology can damage science.

Keywords: CRISPR, Cas9, patent, science, research, commercialization, technology, biotechnology, collaboration

JEL Classification: K00, K23, K41, O3, O34, D23, K11

Suggested Citation

Sherkow, Jacob S., Pursuit of Profit Poisons Collaboration (April 7, 2016). Nature, vol. 532, pp. 172-173; NYLS Legal Studies Research Paper No. 2789283. Available at SSRN: https://ssrn.com/abstract=2789283

Jacob S. Sherkow (Contact Author)

New York Law School ( email )

185 West Broadway
New York, NY 10013
United States
212.431.2355 (Phone)

HOME PAGE: http://www.nyls.edu/faculty/faculty-profiles/faculty_profiles/jacob-s-sherkow/

Columbia University - Department of Health Policy and Management ( email )

600 West 168th Street, 6th Floor
New York, NY 10032
United States

Center for Advanced Studies in Biomedical Innovation Law ( email )

Studiestraede 6
Studiestrade 6
Copenhagen, DK-1455
Denmark

HOME PAGE: http://jura.ku.dk/cebil/staff/

Register to save articles to
your library

Register

Paper statistics

Downloads
27
Abstract Views
306
PlumX Metrics